May 28, 2019Aravax to Present Additional PVX108 Phase 1 Clinical Trial Safety Results at EAACI 2019 May 28, 2019, Melbourne, Victoria – Data show that PVX108 demonstrates exceptional safety in adults with peanut allergy Aravax, a...